Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma

Yasuhiro Oki, Jason R. Westin, Francisco Vega, Hubert Chuang, Nathan Fowler, Sattva Neelapu, Fredrick B. Hagemeister, Peter Mclaughlin, Larry W. Kwak, Jorge E. Romaguera, Michelle Fanale, Anas Younes, Maria Alma Rodriguez, Robert Z. Orlowski, Michael Wang, Souzanne T. Ouzounian, Felipe Samaniego, Luis Fayad

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences